Evidence map›Paper›PMID 42063212›Full record

ArticleBioinformatics (Oxford, England)2026

Interpretable deep survival analysis of Alzheimer's disease via metabolic genetic variants.

Sungwoo Goo, Soyoung Lee, Jung-Woo Chae, Sangkeun Jung, Hwi-Yeol Yun

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sungwoo GooCollege of Pharmacy, Chungnam National University, Daejeon, 34134, Republic of Korea.ORCID 0000-0003-2809-5921
Soyoung LeeCollege of Pharmacy, Chungnam National University, Daejeon, 34134, Republic of Korea.ORCID 0000-0001-5799-4489
Jung-Woo ChaeCollege of Pharmacy, Chungnam National University, Daejeon, 34134, Republic of Korea.ORCID 0000-0001-6026-7063
Sangkeun JungDepartment of Bio-AI convergence, Chungnam National University, Daejeon, 34134, Republic of Korea.ORCID 0000-0003-3531-0618
Hwi-Yeol YunCollege of Pharmacy, Chungnam National University, Daejeon, 34134, Republic of Korea.ORCID 0000-0001-8793-2449

Funding

Artificial Intelligence Convergence Innovation Human Resources Development (Chungnam National University)Basic Science Research Program through the National Research Foundation of Korea (NRF)Chungnam National UniversityCore Technology Development Project for Environmental Diseases Prevention and ManagementEnergy (MOTIE)Institute of Information & Communications Technology Planning Evaluation (IITP)Korea Environmental Industry & Technology Institute (KEITI)Korea government RS-2022-NR070856Korea government RS-2023-00278597Korea government (MSIT) RS-2022-00155857Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)Korea Institute for Advancement of Technology (KIAT) 26212MFDS008Korea Institute for Advancement of Technology (KIAT) RS-2024-00434342Korea Institute of Toxicology (KIT) 2710008763Korea Institute of Toxicology (KIT) KK-2401-01Korea Machine Learning Ledger Orchestration for Drug Discovery Project (K-MELLODDY)Korea Ministry of Environment (MOE) RS-2021-KE001333Ministry of Education RS-2025-25397599Ministry of Food and Drug Safety (MFDS)Ministry of Health & Welfare RS-2024-00336984Ministry of Health & Welfare RS-2025-02306055Ministry of Health & Welfare and Ministry of Science and ICT RS-2024-00460694Ministry of TradeNational Research Foundation of Korea (NRF)Senior Health Convergence Research Center based on Life Cycle (Chungnam National University)]
6 · The paper itself

Abstract

backgroundAlzheimer's disease (AD) is a progressive neurodegenerative disease. Traditional models for estimating AD onset cannot capture nonlinear interactions (epistasis) among the numerous genetic variables that contribute to AD risk.

methodsWe developed a feedforward neural network (FFN)-Weibull survival model to predict AD onset using large-scale single-nucleotide polymorphism (SNP) data. We integrated an XAI technique, Shapley additive explanations (SHAP), to address the black-box nature of deep learning, interpret model predictions, and quantify the contribution of each genetic factor to AD.

resultsThe FFN model achieved a mean concordance index of 0.647, demonstrating an approximately 3.6% improvement over the traditional linear baseline (0.625). The FFN-SHAP model validated established findings, identifying APOE E4 as a primary AD risk factor. APOE E2 strongly protected against AD. Metabolic-disorder-related SNPs had conflicting effects, suggesting gene-environment interactions influence AD onset.

conclusionsBy effectively bypassing the combinatorial explosion of interaction terms, the predictive power of an FFN combined with XAI provides a robust methodological tool for identifying the genetic basis of complex diseases, even in cohorts with limited sample sizes. Our model generated novel testable hypotheses regarding the intricate roles of gene-gene and gene-environment interactions in AD pathogenesis.

Indexed as

Alzheimer DiseaseDeep LearningGenetic Predisposition to DiseaseHumansPolymorphism, Single NucleotideSurvival Analysis

Identifiers

PMID42063212
PMCPMC13224968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.